Association of the R485K polymorphism of the Factor V gene with poor response to activated protein C and increased risk of coronary artery disease in the Chinese population

Clinical Genetics

Volumn 57, Issue 4, 2000, Pages 296-303

  Le, Wei ^a   Yu, Jin De ^a   Lu, Lin ^a   Tao, Rong ^a   You, Bei ^a   Cai, Xu ^a   Cao, Wen Jun ^a   Huang, Wei ^a   He, Ru Min ^a   Zhu, Ding Liang ^b   Chen, Zhu ^a   Gong, Lang Sheng ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Activated protein C; Coagulation factor V; Coronary artery disease; Polymerase chain reaction denaturing gradient gel electrophoresis

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5; DNA;

ADULT; AGED; ARTICLE; CHINESE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DENATURING GRADIENT GEL ELECTROPHORESIS; DEVICE; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC RISK; HIGH RISK POPULATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ACTIVATED PROTEIN C RESISTANCE; AGED; CHINA; CORONARY DISEASE; ELECTROPHORESIS, AGAR GEL; EXONS; FACTOR V; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK FACTORS; SEQUENCE ANALYSIS, DNA;

EID: 0034053358     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.2000.570409.x     Document Type: Article

References (16)

1. Nachman RL, Silverstein AI. Hypercoagulable states. Ann Intern Med 1993: 119: 819-827.
2. Kalafatis M, Mann KG. Factor V Leiden and thrombophilia. Arterioscler Thromb Vase Biol 1997: 17: 620-627.
3. Camire RM et al. The mechanism of inactivation of human platelet factor Va from normal and activated protein C-resistant individuals. J Biol Chem 1995: 270: 20794-20800.
4. Lunghi B et al. Detection of new polymorphic markers in the factor V gene: association with factor V levels in plasma. Thromb Haemost 1996: 75: 45-48.
5. Chan WP et al. A novel mutation of Arg306 of factor V gene in Hong Kong Chinese. Blood 1998: 91: 1135-1139.
6. Koster T et al. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study. Lancet 1993: 342: 1503-1506.
7. Griffin JH et al. Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood 1993: 82: 1989-1993.
8. Svensson PJ, Dahlback B. Resistance to activated protein C as a basis for venous thrombosis. New Engl J Med 1994: 330: 517-522.
9. Dahlback B. Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thrombosis. Blood 1995: 85: 607-614.
10. Rosendaal RF et al. Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood 1997: 89: 2817-2821.
11. Rees DC et al. World distribution of factor V Leiden. Lancet 1995: 346: 1133-1134.
12. De Ronde H, Bertina RM. Laboratory diagnosis of APC resistance: a critical evaluation of the test and the development of diagnostic critic. Thromb Haemost 1994: 72: 880-886.
13. Rosen S et al. Multicenter evaluation of a kit for activated protein C resistance on various coagulation instruments using plasma from healthy individuals. Thromb Haemost 1994: 72: 255-260.
14. Bertina RM et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994: 369: 64-67.
15. Sambrook J et al. Molecular Cloning. New York: Cold Spring Harbor Laboratory Press, 1989: 463-469.
16. Gandrille S et al. Incidence of activated protein C resistance caused by the Arg506G1n mutation in factor V in 113 unrelated symptomatic protein C-deficient patients. Blood 1995: 86: 219-224.